Trailblazing Therapy: IBR900 Cellular Injection Enters Phase I Trial
On July 1, 2025, the initiation meeting for the Phase I clinical trial of IBR900…
Articles
Complicated Intra Abdominal Infections Guidelines
Introduction One hundred years ago, the mortality rate from complicated intra abdominal infections (cIAI) was…
Is Multiple Sclerosis Stealing Your Energy—Or Just Your Focus?
Multiple sclerosis (MS) is a chronic autoimmune disease that affects the central nervous system (CNS),…
Is Chronic Hepatitis C Curable? Discover 6 Vital Facts
Introduction Millions of Americans are infected with hepatitis C and don’t even know it. Hepatitis…
Dato DXd (ADC) Approved by U.S. FDA for Lung Cancer
Dato DXd (datopotamab deruxtecan) has received U.S. FDA approval – a breakthrough milestone announced jointly…
Bio-Thera’s Anti VEGF Therapy for w-AMD Meets Phase III Endpoint, Prepares for Market Filing
— Reported by DengYueMed On June 24, 2024, Bio-Thera Solutions, Ltd. announced that its anti…
Molecular Glues: The Next Golden Track in Drug Discovery
Molecular Glues: Unique Mechanism Of Action Wide Market Prospects Earlier this year, AbbVie announced a…
Krazati (Adagrasib): A Comprehensive Guide for Lung Cancer Patients
Krazati (adagrasib) is a promising targeted therapy developed to treat certain cancers with a specific…
Amvuttra (Vutrisiran) Injection: A Comprehensive Patient Guide
Introduction Amvuttra dosing (vutrisiran) is a new-generation RNA interference (RNAi) therapy used for the treatment…
Can You Recover From Breast Cancer? Breast Cancer Symptoms & Treatments
Introduction Diagnosed with breast cancer? You’re not alone. Explore this blog to understand what breast…